Project Grant K23DA062822
Award Date
4/15/25
Completion Date
3/31/30
Dollars Obligated
$190K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will assess the impact of New York State's Medicaid Value-Based Payment (VBP) policy on outcomes related to opioid use disorder (OUD), including service utilization, quality of care, overdose, and healthcare costs. The $1,329,844 award, with a performance period from August 1, 2024 to May 31, 2029, will leverage a natural experiment to determine the overall...
This $4,112,069 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a mixed-methods study to examine the effects of Medicaid Managed Care Organization (MCO) entries and exits on provider networks, quality of care, and health care utilization for Medicaid enrollees with substance use disorders. The study will use national Medicaid data to investigate these effects using a difference-in-differences...
This federal Project Grant award, with a total funding amount of $2,542,500.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports the development of novel econometric research methods and a unified framework to integrate real-world evidence (RWE) into the analysis of inconclusive randomized controlled trials (RCTs) for opioid use disorder (OUD) treatments. This innovative approach aims to enhance the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $106,714 to support a dissertation project examining the impact of the criminal legal system on opioid use disorder (OUD) treatment and recovery. The key objectives of the project are to: 1) Analyze the influence of the criminal legal system on the language used to discuss OUD treatment and recovery in high-impact communities, 2) Assess the...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: Conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD using claims and emergency department data (Specific Aim 1). Use an evidence-based quality...
This $1,377,306 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), will fund a multi-jurisdictional study aimed at transforming the evidence base on the prevalence of opioid use disorder (OUD) and the impact of opioid agonist treatment (OAT) in preventing opioid-related deaths. The study will leverage data linkages across sites in the U.S. (Rhode Island, Wisconsin, Colorado, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) totaling $459,045 aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the evolving treatment landscape. The project will link data across multiple public health systems in Los Angeles County, including primary care, emergency departments, inpatient facilities, and specialty substance use treatment, to construct a...
The National Institute on Drug Abuse (NIDA) awarded a $564,326 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of Columbia University in the City of New York, Health Sciences Division. The project, titled "Leveraging Harmonized Data to Improve External Validity and Efficiency of Clinical Trials for Treating Opioid Use Disorder," aims to develop new statistical methods for combining data from multiple clinical trials to enhance the power...
This $2,426,074 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs will support research to compare the effects of different medications for opioid use disorder (MOUD) on inflammation and neurocognition in people living with HIV. The research, led by Yale University, aims to evaluate how opioid agonist versus antagonist MOUD treatments impact inflammation and epigenetic changes in the central nervous system of...
This Project Grant award in the amount of $715,238 was issued on January 15, 2025 by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The project will conduct a large-scale genetic study involving a survey of 500,000 diverse individuals to investigate the genetic basis of opioid-related traits and opioid use disorder (OUD). The research aims to elucidate genetic risk factors across the stages of opioid use, from initial use...